Stryker

270 articles with Stryker

• Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China

  6/24/2022

  Stryker, a leading medical technologies company, attended the 6th World Intelligence Congress in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market.

• 

  What Employers Really Look For in Medical Sales Candidates

  6/22/2022

  BioSpace spoke with Jay Johnson, the Director of Talent Acquisition for Orthopedics at Stryker, to find out what it takes to land a job in medical sales.

• Stryker Receives FDA Clearance for Q Guidance System for Spine Applications

  5/31/2022

  Stryker (NYSE:SYK) today announced that its Q Guidance System received 510(k) clearance from the U.S. Food and Drug Administration.

• Stryker Launches EasyFuse™ Dynamic Compression System for High-Demand Foot and Ankle Applications

  5/25/2022

  Stryker (NYSE:SYK) today announced the launch of its EasyFuse™ Dynamic Compression System.

• Stryker announces board changes following Annual Meeting of Shareholders

  5/5/2022

  Stryker announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee.

• Stryker's InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery

  5/3/2022

  Stryker (NYSE: SYK) announced today the publication of results from a multicenter, single-blinded, randomized controlled trial comparing Stryker's InSpace implant with partial repair for the treatment of full-thickness massive irreparable rotator cuff tears (MIRCTs) in the Journal of Bone and Joint Surgery (JBJS).

• Stryker reports first quarter 2022 operating results

  4/28/2022

  We delivered solid first quarter results in the face of a challenging macroeconomic environment.

• Stryker Launches Insignia® Hip Stem at the American Academy of Orthopaedic Surgeons (AAOS) 2022 Annual Meeting

  3/22/2022

  Stryker's Joint Replacement Division announced the introduction of the Insignia® Hip Stem, engineered to optimize patient fit and surgeon ease of implantation in muscle-sparing approaches for total hip and hemiarthroplasty procedures, at the American Academy of Orthopaedic Surgeons 2022 Annual Meeting in Chicago.

• Stryker Launches PROstep™ MICA® SOLO Guide to Simplify Minimally Invasive Bunion Procedures

  2/24/2022

  Stryker Launches PROstep™ MICA ® SOLO Guide to Simplify Minimally Invasive Bunion Procedures.

• Stryker to participate in Cowen 42nd Annual Health Care Conference

  2/15/2022

  Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation scheduled for 10:30 a.m. Eastern Time.

• Stryker declares a $0.695 per share quarterly dividend - Feb 02, 2022

  2/2/2022

  Stryker announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable April 29, 2022 to shareholders of record at the close of business on March 31, 2022, representing an increase of 10.3% versus the prior year and unchanged from the previous quarter.

• Stryker reports 2021 operating results and 2022 outlook

  1/27/2022

  In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020.

• Stryker Announces First Patient Case Using New Tornier Perform® Patient-Matched Primary Reversed Glenoid

  1/20/2022

  Stryker Announces First Patient Case Using New Tornier Perform ® Patient-Matched Primary Reversed Glenoid.

• Stryker announces definitive agreement to acquire Vocera Communications

  1/6/2022

  Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc.

• Stryker to host conference call on January 27, 2022

  1/5/2022

  Stryker announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2021 and provide an operational update.

• Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications

  12/27/2021

  Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company.

• Stryker declares a $0.695 per share quarterly dividend

  12/9/2021

  Stryker announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable January 31, 2022 to shareholders of record at the close of business on December 31, 2021, representing an increase of 10.3% versus the prior year and previous quarter.

• Stryker Launches New Prophecy Infinity Resect-Through Guides

  11/16/2021

  Stryker launched the Prophecy® Infinity® Resect-Through Guides for use in total ankle replacement surgeries.

• Stryker reports third quarter 2021 operating results

  10/28/2021

  In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020.

• Stryker to host conference call on October 28, 2021

  9/23/2021

  Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2021 and provide an operational update.